In summary, the present study confirms that MMP15, MRPL48, CALN1 and HADHB genes are responsible for CTX sensitivity in CRC, which is the first time to explore genes related to CTX sensitivity by CRISPR-Cas9, providing a theoretical basis for further research on drug-sensitivity mechanism of CRC. The gene discussed is MMP15; the disease is colorectal carcinoma.